Diverseome Trust (The) (LSE:DIVI) Research & Development: £0.00 Mil (TTM As of Nov. 2025)


LSE:DIVI Diverse Income Trust (The) PLC LSE:DIVI
33 GF Score
Price £1.18
! 6 Warning Signs
View Full Analysis

What is Diverseome Trust (The) Research & Development?

Diverseome Trust (The) LSE:DIVI 33 Research & Development is £0.00 Mil as of Nov. 2025. GuruFocus rates LSE:DIVI with a GF Score™ of 33/100. The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Diverseome Trust (The)'s Research & Development for the six months ended in Nov. 2025 was £0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Nov. 2025 was £0.00 Mil.


Diverseome Trust (The)  (LSE:DIVI) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Diverseome Trust (The) Research & Development Related Terms


Diverseome Trust (The) Research & Development Historical Data

* Premium members only.

The historical data trend for Diverseome Trust (The)'s Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diverseome Trust (The) Research & Development Chart

Diverseome Trust (The) Annual Data
Trend May16 May17 May18 May19 May20 May21 May22 May23 May24 May25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Diverseome Trust (The) Semi-Annual Data
May16 Nov16 May17 Nov17 May18 Nov18 May19 Nov19 May20 Nov20 May21 Nov21 May22 Nov22 May23 Nov23 May24 Nov24 May25 Nov25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LSE:DIVI
33GF Score
Diverse Income Trust (The) PLC LSE:DIVI
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Diverseome Trust (The) Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Nov. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of £0.00 Mil mean?
Diverseome Trust (The) (LSE:DIVI) has a Research & Development of £0.00 Mil as of Nov. 2025. Research and development expense is the total cost for research and development activities. View historical data on Diverseome Trust (The) and its competitors.
Is Diverseome Trust (The)'s Research & Development too high?
Diverseome Trust (The)'s current Research & Development is £0.00 Mil. Overall, Diverseome Trust (The) has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Diverseome Trust (The)'s Research & Development compare to BLK and BX?
Diverseome Trust (The)'s Research & Development of £0.00 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Diverseome Trust (The) and its competitors. Diverseome Trust (The)'s current Research & Development is £0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diverseome Trust (The) stock overvalued right now?
Diverseome Trust (The) (LSE:DIVI) has a current Research & Development of £0.00 Mil. The current Research & Development is £0.00 Mil. Diverseome Trust (The)'s overall GF Score™ is 33/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Diverseome Trust (The) (LSE:DIVI), the current Research & Development is £0.00 Mil as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Diverseome Trust (The) Business Description

Address 51 Lime Street, 19th Floor, London, GBR, EC3M 7DQ
Diverse Income Trust (The) PLC is a UK-based closed-end investment fund. The company mainly invests in quoted or traded UK companies with a wide range of market capitalizations but a long-term bias toward small and mid-cap equities. It adopts a stock-specific approach in managing the company's portfolio and therefore sector weightings are of secondary consideration. The company also utilizes derivative instruments including index-linked notes, contracts for differences, covered options, and other equity-related derivative instruments for efficient portfolio management, gearing, and investment purposes. Its main objective is to pay shareholders a good and growing dividend income.
33GF Score

Get the complete analysis for LSE:DIVI

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£1.18
Price